Danaher logo

Danaher

Stock
Stock
Ticker: DHR
DHR

Price

Price

CHART BY

Historical dividends and forecast

Danaher has so far distributed $1.12 in 2026. The next dividend will be paid on 30.10.2026

$0.401

CHART BY

Frequently asked questions

The market capitalization of Danaher is $163.13B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
The Price-to-Earnings (P/E) ratio (TTM) for Danaher is 37.97. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
Danaher's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $6.107. EPS indicates the company's profitability on a per-share basis.
Currently, 28 analysts cover Danaher's stock, with a consensus target price of $259.95. Analyst ratings provide insights into the stock's expected performance.
Over the trailing twelve months, Danaher reported a revenue of $25.61B.
Yes, Danaher is paying dividends. The next payment is scheduled for 30.10.2026, with an expected amount of .
Danaher's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $7.99B. EBITDA measures the company's overall financial performance.
Danaher has a free cash flow of $5.73B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
Danaher employs approximately 60,000 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
The free float of Danaher is 640.36M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$163.13B
EPS (TTM) 
$6.107
Free Float 
640.36M
P/E ratio (TTM) 
37.97
Revenue (TTM) 
$25.61B
EBITDA (TTM) 
$7.99B
Free Cashflow (TTM) 
$5.73B

Pricing

1D span
$230.45$233.35
52W span
$160.93$242.80

Analyst Ratings

The price target is $259.95 and the stock is covered by 28 analysts.

Buy

24

Hold

4

Sell

0

Information

Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, and Diagnostics. The Biotechnology segment includes bioprocessing, discovery, and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.

Employees
60,000
Industries
Medical Specialties
Sector
Health Care

Identifier

Primary Ticker
DHR

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation
Sign upLogin